OTCMKTS:PHMMF Pharma Mar (PHMMF) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free PHMMF Stock Alerts $26.85 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$26.85▼$26.8550-Day Range$26.85▼$44.1352-Week Range$26.85▼$46.26VolumeN/AAverage Volume19 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Pharma Mar alerts: Email Address Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. About Pharma Mar Stock (OTCMKTS:PHMMF)Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14, which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trial for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trial for treating solid tumors; Tivanisiran, which is in Phase III clinical trial for the treatment of dry eye disease; and SYL1801 that is in phase II clinical trial for treating macular degeneration. In addition, it engages in the development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.Read More PHMMF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PHMMF Stock News HeadlinesMarch 18, 2024 | markets.businessinsider.comPharming Group’s Strong Performance and Growth Prospects Justify Buy RatingMarch 16, 2024 | newsweek.comMar-a-lagoApril 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…March 7, 2024 | markets.businessinsider.comPersica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back painFebruary 17, 2024 | investing.comPharma Mar SAU (PHMR)February 1, 2024 | investorplace.comPfizer’s 2024 Comeback: A Dividend Gem in the Pharma MarketJanuary 9, 2024 | msn.comTwo new databases combine computer science and pharmaceutical researchNovember 29, 2023 | msn.comFirst West Africa Healthcare, Lab, & Pharma Week 2024 To Hold In NigeriaApril 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…November 6, 2023 | morningstar.comPharma Mar SA PHMOctober 28, 2023 | markets.businessinsider.comPiramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024July 15, 2023 | barrons.comPharma Mar S.A.June 21, 2023 | forbes.comYifan PharmaceuticalJune 6, 2023 | finance.yahoo.comPHM.MC - Pharma Mar, S.A.April 22, 2023 | msn.comNEEDHAM & COMPANY INC. Maintains Pharma Mar (XMAD:PHM) Buy RecommendationMarch 27, 2023 | marketwatch.comPharmaceutical Excipients Market Top Players By 2031March 25, 2023 | news.yahoo.comPharmaceutical company to open in McHenryMarch 24, 2023 | markets.businessinsider.comInnate Pharma (IPHA) Receives a Buy from H.C. WainwrightMarch 16, 2023 | bizjournals.comBig Pharma companies back new startup out of Mass General BrighamNovember 9, 2022 | markets.businessinsider.comPiramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023October 10, 2022 | yahoo.comEuropean Commission suspects pharma group Teva broke antitrust rulesAugust 30, 2022 | apnews.comPharmacists Database List of Emails, Phone Numbers, Contact InformationJanuary 11, 2022 | finance.yahoo.comLife Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variantsNovember 11, 2021 | finanznachrichten.dePharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in TaiwanOctober 28, 2021 | news.yahoo.comSpain's PharmaMar posts 58% drop in 9-mth profit despite higher revenuesOctober 28, 2021 | reuters.comSpain's PharmaMar nine-month net profit falls 58%July 29, 2021 | nasdaq.comSpain's PharmaMar sales rise on demand for cancer treatmentsSee More Headlines Receive PHMMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharma Mar and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:PHMMF Previous SymbolNASDAQ:PHMMF CUSIPN/A CIKN/A Webwww.pharmamar.com Phone(491) 846-6000Fax34-91-846-6001Employees509Year Founded1986Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.13 Current Ratio3.01 Quick Ratio2.61 Sales & Book Value Annual Sales$171.15 million Price / SalesN/A Cash Flow$3.23 per share Price / Cash Flow8.30 Book Value$13.04 per share Price / Book2.06Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.20 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Jose Maria Fernandez Sousa-Faro Ph.D.Founder, Executive Chairman, CEO & PresidentMr. Pedro Francisco Fernandez PuentesExecutive DirectorMr. Juan Carlos-Torres Carretero (Age 75)Founder Ms. María Luisa de Francia CaballeroChief Financial OfficerMr. José Luis Moreno Martinez-LosaDirector of Capital Markets & Investor RelationsMr. Juan Gomez PulidoGeneral Counsel & Secretary of the Board of DirectorsMs. Sandra Llamera SanchezGlobal Compliance HeadMs. Lara VadilloCommunication DirectorMs. Belén Sopesén Veramendi Ph.D.Director of Corporate DevelopmentMr. Luis Rupérez CuencaDirector of Human Resources & ITMore ExecutivesKey CompetitorsbioMérieuxOTCMKTS:BMXMFDiaSorinOTCMKTS:DSRLFMDxHealthNASDAQ:MDXHRecordati Industria Chimica e FarmaceuticaOTCMKTS:RCDTFRespiriOTCMKTS:KMLXFView All Competitors PHMMF Stock Analysis - Frequently Asked Questions How have PHMMF shares performed in 2024? Pharma Mar's stock was trading at $46.26 at the start of the year. Since then, PHMMF shares have decreased by 42.0% and is now trading at $26.85. View the best growth stocks for 2024 here. How do I buy shares of Pharma Mar? Shares of PHMMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PHMMF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma Mar, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.